Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
FLRT2 prevents endothelial cell senescence and vascular aging by regulating the ITGB4/mTORC2/p53 signaling pathway
Hyun Jung Hwang, Donghee Kang, Jae-Ryong Kim, Joon Hyuk Choi, Ji-Kan Ryu, Allison B. Herman, Young-Gyu Ko, Heon Joo Park, Myriam Gorospe, Jae-Seon Lee
Hyun Jung Hwang, Donghee Kang, Jae-Ryong Kim, Joon Hyuk Choi, Ji-Kan Ryu, Allison B. Herman, Young-Gyu Ko, Heon Joo Park, Myriam Gorospe, Jae-Seon Lee
View: Text | PDF
Research Article Cell biology Vascular biology

FLRT2 prevents endothelial cell senescence and vascular aging by regulating the ITGB4/mTORC2/p53 signaling pathway

  • Text
  • PDF
Abstract

The roles of fibronectin leucine-rich transmembrane protein 2 (FLRT2) in physiological and pathological processes are not well known. Here, we identify a potentially novel function of FLRT2 in preventing endothelial cell senescence and vascular aging. We found that FLRT2 expression was lower in cultured senescent endothelial cells as well as in aged rat and human vascular tissues. FLRT2 mediated endothelial cell senescence via the mTOR complex 2, AKT, and p53 signaling pathway in human endothelial cells. We uncovered that FLRT2 directly associated with integrin subunit beta 4 (ITGB4) and thereby promoted ITGB4 phosphorylation, while inhibition of ITGB4 substantially mitigated the induction of senescence triggered by FLRT2 depletion. Importantly, FLRT2 silencing in mice promoted vascular aging, and overexpression of FLRT2 rescued a premature vascular aging phenotype. Therefore, we propose that FLRT2 could be targeted therapeutically to prevent senescence-associated vascular aging.

Authors

Hyun Jung Hwang, Donghee Kang, Jae-Ryong Kim, Joon Hyuk Choi, Ji-Kan Ryu, Allison B. Herman, Young-Gyu Ko, Heon Joo Park, Myriam Gorospe, Jae-Seon Lee

×

Figure 3

FLRT2 specifically binds ITGB4 and regulates ITGB4 phosphorylation in lipid rafts of the plasma membrane.

Options: View larger image (or click on image) Download as PowerPoint
FLRT2 specifically binds ITGB4 and regulates ITGB4 phosphorylation in li...
(A) HUVECs were transfected with Con Si, FGFR1 Si, VEGFR2 Si, EGFR Si, or ITGB4 Si (first transfection) 6 hours before transfection with Con Si or FLRT2 Si (second transfection). At day 2 after transfection, the cells were harvested and subjected to immunoblotting using the indicated antibodies. (B) Immunoblot assay was performed at the indicated time points after transfection of Con Si or FLRT2 Si. (C) Immunocytochemical staining was performed at day 2 after transfection of Con Si or FLRT2 Si. Scale bar: 20 μm. (D) HUVECs were transfected with a FLAG-tagged, FLRT2-overexpressing construct. At day 2 after transfection, cell lysates were subjected to immunoprecipitation with anti-FLAG antibody and immunoblotted with the indicated antibodies. (E) Immunofluorescence of nonpermeabilized HUVECs that were stained with antibodies recognizing FLRT2 or ITGB4. Scale bar: 20 μm. (F) Representative images of individual immunofluorescence staining of FLRT2 and ITGB4 interaction in HUVECs by Duo-link assay. The red dots (FLRT2/ITGB4 interaction) indicate direct interaction. Original magnification, ×40 (top) and ×200 (bottom). Scale bar: 10 μm. (G) HUVECs were transfected with Con Si or FLRT2 Si and incubated for 2 days. The lipid rafts were fractionated. Equal volumes of lipid rafts (Rafts; fractions 6–8) and nonlipid rafts (Nonrafts; fractions 2–4) were separated by SDS-PAGE and immunoblotted with the indicated antibodies.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts